C

Globus Medical, Inc. GMED

$78.68 -$0.28-0.36% NYSE
Recommendation
Dividend Power Score
Day's Range
$77.96$79.95
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

GMED Rating

Reward
Risk

GMED Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

GMED Company Overview

Globus Medical, Inc. is a U.S.-based medical device company focused on the musculoskeletal healthcare market, with a primary emphasis on spinal surgery, orthopedic trauma, joint reconstruction, and enabling technologies. The company develops and commercializes implantable devices, biologics, navigation systems, robotic-assisted surgery platforms, and procedural solutions used by surgeons and healthcare systems. Globus Medical operates within the broader medical technology and orthopedic devices industry and generates revenue primarily through sales of spinal implants, orthopedic products, enabling technologies, and related surgical solutions.

The company was founded in 2003 by spine industry veterans including David C. Paul and grew rapidly through product innovation and surgeon-focused design. Over time, it expanded from a spine-focused manufacturer into a broader musculoskeletal technology company through internal development and acquisitions, most notably the merger with NuVasive, Inc. completed in 2023. Globus Medical is positioned competitively through its integrated product ecosystem, strong surgeon relationships, vertically integrated manufacturing capabilities, and focus on procedural efficiency and enabling technologies such as navigation and robotics.

Data compiled by narrative technology. May contain errors.
Sector

GMED Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

GMED Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

GMED Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

GMED Price History

Loading...
52-Week Range46% of range
Current
$78.68
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

GMED Valuation

Market Cap
Market Cap Rank
#2,348
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

GMED Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

GMED Corporate Info

Phone Number
610 930 1800
Address
2560 General Armistead Avenue
Audubon, PA 19403-5214
Country
Year Founded

GMED Filings

Filing Date
Thursday, August 6, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)

GMED Headlines

10/16/2026 - Zacks Investment Research
10/16/2026 - Zacks Investment Research